Economy

Trump backs down from 250% EU pharma tariff in deal

Trump halts 250% tariff on EU pharma in latest agreement

The rising trade disputes between Washington and Brussels reached a pivotal point when former U.S. President Donald Trump decided to abandon proposals to introduce an unusually steep tariff—allegedly 250 percent—on pharmaceutical goods imported from the European Union. This move, included in a broader trade agreement, represents a crucial development in the prolonged discussions between the two significant economic forces and provides a temporary relief for businesses on both sides of the Atlantic.The dispute traces back to a period of intensifying trade frictions, during which Washington sought to correct what it viewed as persistent imbalances and unfair practices in sectors ranging…
Read More
WH Smith shares tumble 42% after accounting blunder

WH Smith experiences 42% share plunge after accounting blunder

Shares in WH Smith experienced a dramatic decline following the disclosure of a significant accounting miscalculation that has rattled investors and raised questions about the company’s internal controls. The retail group, best known for its presence in airports, train stations, and high streets across the United Kingdom and internationally, saw its market value drop sharply after admitting to a financial oversight that inflated reported earnings.The news caused a significant stir in the investment world, as WH Smith's share value dropped by over 40% during the initial trading hours. Experts characterized this as among the toughest financial reporting challenges the company…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump reverses 250% EU pharma tariff following deal

The possibility of a trade war between the United States and the European Union has been averted after former U.S. President Donald Trump agreed to drop plans for a massive tariff on European pharmaceutical imports. Initially, the Trump administration had signaled the introduction of a 250% tariff on drugs coming from Europe, a move that alarmed both industry leaders and healthcare organizations worldwide. However, following weeks of tense negotiations, both sides have announced a deal aimed at maintaining stability in the global pharmaceutical market.The proposed tariff emerged as part of a broader strategy designed to protect American manufacturing and reduce…
Read More
Target appoints new boss as it seeks to revive sales

Target appoints new chief executive in bid to revive sales

Target Corporation has revealed a major executive shift, selecting a new CEO as it seeks to boost sales and reshape its standing in the competitive retail sector. This decision arises in response to increasing pressure from shareholders and industry experts who have observed stagnant growth and evolving consumer trends in recent times. The choice underscores Target's dedication to strategic revitalization and enduring stability.The retail giant faces a challenging environment where consumer expectations are evolving rapidly. Online shopping, convenience-focused services, and price-sensitive shoppers have forced traditional retailers to reconsider their approach. Target’s recent performance has highlighted the need for fresh leadership…
Read More
Newsmax settles Dominion election defamation case for m

Newsmax and Dominion settle election defamation lawsuit for $67m

Newsmax has settled its legal disagreement with Dominion Voting Systems by consenting to a $67 million payment, concluding a significant defamation case associated with the 2020 U.S. presidential election. This settlement stops the case from advancing to trial and highlights the financial and reputational impacts that media organizations may encounter when covering claims that are unsupported by verified evidence.Dominion Voting Systems, una empresa que suministró tecnología electoral y máquinas de tabulación en todo Estados Unidos, se convirtió en un objetivo central de campañas de desinformación tras las elecciones de 2020. Acusaciones infundadas sobre la manipulación de resultados por parte de…
Read More
Soho House bought for £2bn as Ashton Kutcher joins board 2 hours ago

Ashton Kutcher joins board in £2bn Soho House buyout

A new chapter has begun for the renowned international private members' club, Soho House, following a recent purchase agreement that places its value at an impressive £2 billion. This essential deal not only underscores a major moment in the hospitality and leisure industry but also introduces a fresh viewpoint to the company's leadership. The move, which includes a prominent figure from the entertainment and technology fields onto its board, signifies a strategic shift for the brand as it seeks to expand its reach and appeal to a new generation of members. The purchase strengthens the club's position as a luxury…
Read More